المؤلفون: Tosca EM; Dipartimento Di Ingegneria Industriale E Dell'Informazione, Università Degli Studi Di Pavia, 27100, Pavia, Italy., Ronchi D; Dipartimento Di Ingegneria Industriale E Dell'Informazione, Università Degli Studi Di Pavia, 27100, Pavia, Italy., Rocchetti M; Consultant, Milan, Italy., Magni P; Dipartimento Di Ingegneria Industriale E Dell'Informazione, Università Degli Studi Di Pavia, 27100, Pavia, Italy. paolo.magni@unipv.it.

المصدر: The AAPS journal [AAPS J] 2024 Aug 08; Vol. 26 (5), pp. 92. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Burden* , Progression-Free Survival* , Neoplasms*/pathology , Neoplasms*/drug therapy, Humans ; Animals ; Mice ; Translational Research, Biomedical/methods ; Xenograft Model Antitumor Assays/methods ; Models, Biological

المؤلفون: Yang L; Sanofi Bridgewater, New Jersey, US., Raveendran G; Sanofi Bridgewater, New Jersey, US., Meng X; Harvard University, Cambridge, MA, US., Lin J; Sanofi, Cambridge, MA, US., Meng Z; Sanofi, Cambridge, MA, US. zhaoling.meng@sanofi.com.

المصدر: BMC cancer [BMC Cancer] 2024 Jul 29; Vol. 24 (1), pp. 912. Date of Electronic Publication: 2024 Jul 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen*/antagonists & inhibitors , Neoplasms*/drug therapy , Neoplasms*/mortality , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Progression-Free Survival*, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Clinical Trials as Topic

المؤلفون: Xiao Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Wu W; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Liu F; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Jia Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Jin L; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Qiao N; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Cai K; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Ru S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Cao L; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Gui S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. guisongbai@ccmu.edu.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Jul 04; Vol. 24 (1), pp. 799. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Craniopharyngioma*/metabolism , Craniopharyngioma*/pathology , Craniopharyngioma*/mortality , Craniopharyngioma*/complications , Pituitary Neoplasms*/mortality , Pituitary Neoplasms*/metabolism , Pituitary Neoplasms*/pathology , Pituitary Neoplasms*/blood , Progression-Free Survival* , Inflammation Mediators*/metabolism , Leptin*/blood , Leptin*/metabolism, Humans ; Female ; Male ; Adult ; Middle Aged ; Prognosis ; Obesity/complications ; Obesity/metabolism ; Obesity, Morbid/complications ; Obesity, Morbid/metabolism ; Obesity, Morbid/mortality ; Young Adult ; Chemokine CXCL1/metabolism ; Chemokine CXCL1/blood ; Age of Onset ; Risk Factors ; Clinical Relevance ; Interleukin-8

المؤلفون: Zemskova O; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.; Department of Radioneurosurgery, Romodanov Neurosurgery Institute, Kyiv, Ukraine., Yu NY; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, U.S.A., Leppert J; Department of Neurosurgery, University of Lübeck, Lübeck, Germany., Rades D; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 3059-3066.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/mortality , Glioblastoma*/pathology , Glioblastoma*/therapy , Neoplasm Recurrence, Local*/pathology , Brain Neoplasms*/mortality , Brain Neoplasms*/pathology , Brain Neoplasms*/therapy , Progression-Free Survival*, Humans ; Male ; Female ; Middle Aged ; Aged ; Prognosis ; Adult ; Retrospective Studies ; Karnofsky Performance Status ; Aged, 80 and over

المؤلفون: Jia J; The Department of Medical Imaging Center, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, No. 1 West Huanghe Road, Huaian, 223300, Jiangsu, PR China., Liu Z; The Department of Medical Imaging Center, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, No. 1 West Huanghe Road, Huaian, 223300, Jiangsu, PR China., Wang F; The Department of Medical Imaging Center, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, No. 1 West Huanghe Road, Huaian, 223300, Jiangsu, PR China., Bai G; The Department of Medical Imaging Center, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, No. 1 West Huanghe Road, Huaian, 223300, Jiangsu, PR China. Electronic address: hybgj0451@163.com.

المصدر: Academic radiology [Acad Radiol] 2024 Jul; Vol. 31 (7), pp. 2807-2817. Date of Electronic Publication: 2024 Jan 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/diagnostic imaging , Esophageal Neoplasms*/pathology , Tomography, X-Ray Computed*/methods , Progression-Free Survival* , Esophageal Squamous Cell Carcinoma*/diagnostic imaging, Humans ; Female ; Male ; Retrospective Studies ; Cluster Analysis ; Middle Aged ; Aged ; Adult ; Consensus ; BRCA1 Protein/genetics ; Aged, 80 and over ; Radiomics

المؤلفون: Erdoğan Özünal I; Division of Hematology, Department of Internal Medicine, Istanbul Medeniyet University, Prof. Dr. Süleyman Yalçın Göztepe City Hospital, Eğitim Mah., Kadıköy, 34722, Istanbul, Turkey. isil.erdogan@medeniyet.edu.tr., Kılıçaslan E; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey., Elibol T; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey., Öztürk E; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

المصدر: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2024 Jul; Vol. 136 (13-14), pp. 398-404. Date of Electronic Publication: 2023 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Austria NLM ID: 21620870R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-7671 (Electronic) Linking ISSN: 00435325 NLM ISO Abbreviation: Wien Klin Wochenschr Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/blood , Multiple Myeloma*/mortality , Multiple Myeloma*/diagnosis , Lipoproteins, HDL*/blood , Progression-Free Survival*, Humans ; Male ; Female ; Middle Aged ; Aged ; Risk Factors ; Biomarkers, Tumor/blood ; Sensitivity and Specificity ; Prognosis ; Survival Rate ; Reproducibility of Results

المؤلفون: Meng N; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China.; Biomedical Research Institute, Henan Academy of Sciences, Zhengzhou, China., Jiang H; Department of Medical Imaging, Xinxiang Medical University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China., Sun J; Department of Pediatrics, Zhengzhou Central Hospital Affiliated to Zhengzhou University & Zhengzhou Central Hospital, Zhengzhou, China., Shen L; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Wang X; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Zhou Y; Department of Medical Imaging, Xinxiang Medical University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China., Wu Y; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Fu F; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Yuan J; Central Research Institute, United Imaging Healthcare Group, Shanghai, China., Yang Y; Beijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China., Wang Z; Central Research Institute, United Imaging Healthcare Group, Shanghai, China., Wang M; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China.; Biomedical Research Institute, Henan Academy of Sciences, Zhengzhou, China.

المصدر: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Jul; Vol. 60 (1), pp. 125-135. Date of Electronic Publication: 2023 Oct 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Fluorodeoxyglucose F18* , Lung Neoplasms*/diagnostic imaging , Positron-Emission Tomography*/methods , Magnetic Resonance Imaging*/methods , Progression-Free Survival*, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Prospective Studies ; Young Adult ; Protons ; Multimodal Imaging ; Radiopharmaceuticals ; Motion ; Prognosis

المؤلفون: Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven; Laboratory of Experimental Oncology, KU Leuven, Leuven; Department of Oncology, Leuven Cancer Institute, Leuven, Belgium., Jones RL; Sarcoma Unit, The Royal Marsden, London; The Institute of Cancer Research, London, UK. Electronic address: robin.jones4@nhs.net., Agulnik M; City of Hope, Department of Medical Oncology & Therapeutics Research, Duarte, USA., Blay JY; Centre Léon Bérard, University Claude Bérard, Lyon, France., Chalmers A; Huntsman Cancer Institute, University of Utah, Salt Lake City, USA., Italiano A; Institut Bergonié, Bordeaux; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Pink D; Department of Hematology, Oncology and Palliative Care, Helios Hospital Bad Saarow, Sarcoma Centre Berlin-Brandenburg, Bad Saarow, Germany., Stacchiotti S; Adult Mesenchymal and Rare Tumours Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Valverde C; Vall d'Hebrón University Hospital, Medical Oncology Department, Barcelona, Spain., Vincenzi B; Policlinico Universitario Campus Bio-Medico, Rome, Italy., Wagner MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle; Division of Medical Oncology, University of Washington, Seattle., Maki R; Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA.

المصدر: ESMO open [ESMO Open] 2024 Jul; Vol. 9 (7), pp. 103487. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Liposarcoma*/therapy , Liposarcoma*/mortality , Liposarcoma*/pathology , Delphi Technique* , Progression-Free Survival* , Consensus*, Humans ; Clinical Trials as Topic ; Europe ; Research Design

عنوان ترانسليتريتد: Fulvestrant in clinical practice: Effectiveness analysis in Uruguayan patients with HR+/HER2- breast cancer.

المؤلفون: Camejo N; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Amarillo D; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Castillo C; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Badía Alza S; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Baliño C; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Banchieri M; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Fagundez J; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Ghiga S; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Lorier M; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Alonso I; Fondo Nacional de Recursos, Montevideo, Uruguay., Krygier Waltier GD; Servicio de Oncología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

المصدر: Medwave [Medwave] 2024 Sep 24; Vol. 24 (8), pp. e2923. Date of Electronic Publication: 2024 Sep 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medwave Estudios Limitada Country of Publication: Chile NLM ID: 101581949 Publication Model: Electronic Cited Medium: Internet ISSN: 0717-6384 (Electronic) Linking ISSN: 07176384 NLM ISO Abbreviation: Medwave Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Receptor, ErbB-2*/metabolism , Fulvestrant*/therapeutic use , Fulvestrant*/administration & dosage , Antineoplastic Agents, Hormonal*/therapeutic use , Progression-Free Survival*, Humans ; Female ; Middle Aged ; Aged ; Follow-Up Studies ; Receptors, Estrogen/metabolism ; Survival Rate ; Adult ; Databases, Factual ; Receptors, Progesterone/metabolism

المؤلفون: He J; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.; Department of Oncology, Ganzhou People's Hospital (The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University), Ganzhou, Jiangxi Province, China., Liao XH; Department of Oncology, Ganzhou People's Hospital (The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University), Ganzhou, Jiangxi Province, China., Zhong BD; Department of Oncology, Ganzhou People's Hospital (The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University), Ganzhou, Jiangxi Province, China., Liu AW; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.

المصدر: Medicine [Medicine (Baltimore)] 2024 Sep 20; Vol. 103 (38), pp. e39299.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/therapy , Uterine Cervical Neoplasms*/mortality , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/metabolism , Chemoradiotherapy*/methods , Progression-Free Survival*, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Biomarkers, Tumor/metabolism ; Prognosis ; Aged ; Cisplatin/therapeutic use ; Transcription Factors/metabolism